Seppic, through its subsidiary Serdex, has been an active member of the UEBT (Union for Ethical BioTrade) since 2008, and is committed, along with more than 40 other companies, to the Action for Nature & People initiative. This joint commitment is to promote and develop a responsible sourcing model for ingredients derived from biodiversity, with respect for people and the environment.

Serdex contributes through its commitment to preserve biodiversity, to respect traditional know-how, to improve the living conditions of local populations and to develop a strong partnership with local suppliers in the areas where the plants are collected. In doing so, Serdex guarantees a sustainable supply chain, in accordance with the principles of the Nagoya Protocol, and provides its customers with ingredients that respect biodiversity and local communities.

Serdex meets 96.5% of the UEBT membership requirements and again improves its score from the last audit*. The requirements of the UEBT standard apply to all supply activities through which ingredients are produced, processed and obtained. Serdex has chosen to improve the ethical practices of its Centella Asiatica supply chain in Madagascar, covering the entire supply chain, from suppliers to the more than 3,000 pickers associated with it.

Jean Baptiste Dellon, CEO of Seppic, says"Our commitment to developing a sustainable sourcing model reflects Seppic's CSR ambition as expressed in its "Caring" program in which Seppic commits to help everyone to live in a healthy environment and create sustainable relationships with its stakeholders. "

*audits d'adhésion à l'UEBT réalisés en 2017 et 2020 par Ecocert sur la base du référentiel Ethical BioTrade

Seppic in brief

A company of Air Liquide Healthcare, Seppic has been designing, producing and distributing for more than 75 years a wide range of specialty ingredients for health and beauty. Present in 100 countries through its subsidiaries and its network of distributors, Seppic employs more than 820 people worldwide, including 110 employees dedicated to innovation.

Air Liquide Healthcare

Supplies medical gases, home healthcare services, medical equipment and specialty ingredients.

In 2020, it served over 15,000 hospitals and clinics and more than 1.8 million patients at home throughout the world. The Group’s Healthcare business reached €3,724 million in revenues in 2020, with the support of its 15,600 employees.

Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.